Stoke Therapeutics Inc (STOK)

SG&A Expense Growth

37.49%

Fiscal year · Period ending:

STOK logo

STOK SG&A Expense Growth

Latest reported37.49%
STOK FY SG&A Growth (YoY) (0.00% → 37.49%)
High-resolution chart · PNG

STOK sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Stoke Therapeutics Inc SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
37.4923%
18.0824%
6.1607%
22.0303%
53.0052%
74.979%
170.1587%
125.4601%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.